Back
Neurocrine Biosciences Stock Predictions
Disrupting a Trillion-Dollar Industry
Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.
Buy
53
NBIX
Neurocrine Biosciences
Last Price:
$123.08
Seasonality Move:
7.38%
7 Day Trial
ALL ACCESS PASS
$
7
Invest Where Innovation Meets Real Demand
Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.Neurocrine Biosciences Stock Forecast
-
Over the next 52 weeks, Neurocrine Biosciences has on average historically risen by 28.7% based on the past 28 years of stock performance.
-
Neurocrine Biosciences has risen higher in 14 of those 28 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Neurocrine Biosciences Stock Undervalued?The current Neurocrine Biosciences [NBIX] share price is $122.64. The Score for NBIX is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
NBIX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Neurocrine Biosciences Stock Go Up Next Year?
-
Over the next 52 weeks, Neurocrine Biosciences has on average historically risen by 28.7% based on the past 28 years of stock performance.
Neurocrine Biosciences Stock Rating
Buy
53
Neurocrine Biosciences (NBIX)
is a Buy
Is Neurocrine Biosciences overpriced?
-
Neurocrine Biosciences has risen higher in 14 of those 28 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Neurocrine Biosciences Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
neurocrine.com
52-Week Data
52-Week High:
157.98
52-Week Low:
84.23
Prediction Charts
Market Cap:
12.1B
Price in USD:
122.64
Volume:
1.3M
Beta:
0.78
Technical Analysis
SMA50:
109.33
SMA100:
120.13
SMA200:
123.48
52-Wk Change:
-12.02%
Stock Predictions
-
Is Neurocrine Biosciences stock public?Yes, Neurocrine Biosciences is a publicly traded company.
-
What is the Neurocrine Biosciences stock quote today?The Neurocrine Biosciences stock price is 122.64 USD today.
-
How to buy Neurocrine Biosciences stock online?You can buy Neurocrine Biosciences shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| May-7 | 119.24 | 121.61 | 122.57 | 116.57 |
| May-8 | 119.92 | 117.52 | 121.46 | 116.89 |
| May-9 | 118.04 | 115.71 | 119.67 | 115.66 |
| May-12 | 116.21 | 120.43 | 120.87 | 116.01 |
| May-13 | 119.71 | 116.87 | 119.75 | 116.82 |
| May-14 | 117.80 | 118.78 | 121.85 | 116.00 |
| May-15 | 119.91 | 120.27 | 120.40 | 117.40 |
| May-16 | 120.50 | 121.02 | 121.36 | 119.17 |
| May-19 | 120.19 | 122.82 | 123.07 | 120.19 |
| May-20 | 122.61 | 122.96 | 123.99 | 121.87 |
| May-21 | 122.42 | 120.56 | 122.42 | 119.79 |
| May-22 | 119.67 | 119.12 | 120.10 | 118.39 |
| May-23 | 118.05 | 120.18 | 120.30 | 117.59 |
| May-27 | 120.87 | 122.64 | 122.78 | 119.62 |
Neurocrine Biosciences Earnings
Neurocrine Biosciences Earnings Report: Per Share Neurocrine Biosciences Earnings Q1 Q2 Q3 and Q4 last year and next year.
Neurocrine Biosciences Forecast Revenue Growth
Neurocrine Biosciences Stock Analysis: Historical quarterly revenues per share for Neurocrine Biosciences and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.27 per share, a decrease this year of $0.50 per share, and an increase next year of $2.22 per share.
* Neurocrine Biosciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.